Chemokine profiles of interstitial pneumonia in patients with dermatomyositis: a case control study
Authors:
Open Access
- 9 May 2017
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , 1-10
Abstract
Chemokines play an important role in the pathophysiology of dermatomyositis (DM) with interstitial pneumonia (IP). However, the relation between chemokines and the disease activity or prognosis of DM-IP has not been elucidated. We evaluated the serum C-C motif chemokine ligand (CCL) 2, Th1 chemokines (C-X-C motif chemokine ligand [CXCL] 9, CXCL10, CXCL11), and Th2 chemokine (CCL17) profiles of 30 patients, and examined the relation between these chemokines and the disease activity or prognosis of DM-IP. Initial serum CCL2 level was higher in the death group (P = 0.007). To determine the cut-off points effective as poor prognostic factors of DM-IP, ROC curve analysis was carried out on initial serum CCL2 level. The value that maximized the area under the ROC curve was 894 pg/mL (sensitivity: 100%, specificity: 70.8%). Serum CCL2, CXCL9, CXCL10, and CXCL11 levels were lower at 2 weeks after treatment initiation than before treatment. Serum CCL2, CXCL10, and CXCL11 levels at 2 weeks after treatment initiation were higher in the death group. Serum levels of chemokines such as CCL2, CXCL10, and CXCL11 may be possible biomarkers of disease activity and prognosis in DM-IP, and serum CCL2 level may be useful when deciding initial treatment.Keywords
This publication has 49 references indexed in Scilit:
- Limitations of a single-point evaluation of anti-MDA5 antibody, ferritin, and IL-18 in predicting the prognosis of interstitial lung disease with anti-MDA5 antibody-positive dermatomyositisClinical Rheumatology, 2012
- Dysregulation of the type I interferon system in adult‐onset clinically amyopathic dermatomyositis has a potential contribution to the development of interstitial lung diseaseBritish Journal of Dermatology, 2012
- Coadministration of Cyclosporin a with Prednisolone in Acute Interstitial Pneumonia Complicating Polymyositis/DermatomyositisClinical Medicine Insights: Arthritis and Musculoskeletal Disorders, 2012
- Combination with corticosteroids and cyclosporin-A improves pulmonary function test results and chest HRCT findings in dermatomyositis patients with acute/subacute interstitial pneumoniaClinical Rheumatology, 2011
- Increased ferritin predicts development and severity of acute interstitial lung disease as a complication of dermatomyositisRheumatology, 2010
- Successful treatment with tacrolimus of progressive interstitial pneumonia associated with amyopathic dermatomyositis refractory to cyclosporineClinical Rheumatology, 2010
- Characterization and peripheral blood biomarker assessment of anti–Jo‐1 antibody–positive interstitial lung diseaseArthritis & Rheumatism, 2009
- A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis siné myositis): A missing link within the spectrum of the idiopathic inflammatory myopathiesJournal of the American Academy of Dermatology, 2006
- Activation of pulmonary T cells in corticosteroid-resistant and -sensitive interstitial pneumonitis in dermatomyositis/polymyositisClinical and Experimental Immunology, 2002
- Thin-section CT obtained at 10-mm increments versus limited three-level thin-section CT for idiopathic pulmonary fibrosis: correlation with pathologic scoring.American Journal of Roentgenology, 1997